Asthma deaths in New Zealand: whodunnit?

Suppr

超能文献

作者信息

Blauw G J, Westendorp R G

机构信息

Department of Clinical Epidemiology, University Hospital Leiden, Netherlands.

出版信息

Lancet. 1995 Jan 7;345(8941):2-3. doi: 10.1016/s0140-6736(95)91143-x.

DOI:10.1016/s0140-6736(95)91143-x

PMID:7799701

Abstract

摘要

相似文献

Asthma deaths in New Zealand: whodunnit?

Lancet. 1995 Jan 7;345(8941):2-3. doi: 10.1016/s0140-6736(95)91143-x.

International trends in sales of inhaled fenoterol, all inhaled beta-agonists, and asthma mortality, 1970-1992.

J Clin Epidemiol. 1997 Mar;50(3):321-8. doi: 10.1016/s0895-4356(96)00375-7.

Epidemiologic studies of beta agonists and asthma deaths.

Epidemiol Rev. 1998;20(2):173-86. doi: 10.1093/oxfordjournals.epirev.a017979.

Fenoterol and asthma mortality in New Zealand.

N Z Med J. 1990 Feb 28;103(884):73-5.

The use of beta agonists and the risk of death and near death from asthma.β受体激动剂的使用与哮喘导致的死亡及濒死风险。

J Clin Epidemiol. 2009 Jun;62(6):582-7. doi: 10.1016/j.jclinepi.2009.01.004.

Beta-agonist therapy and asthma mortality in Japan.

Lancet. 1998 May 9;351(9113):1406-7. doi: 10.1016/S0140-6736(05)79446-0.

Withdrawal of fenoterol and the end of the New Zealand asthma mortality epidemic.非诺特罗的停用与新西兰哮喘死亡率流行的终结。

Int Arch Allergy Immunol. 1995 May-Jun;107(1-3):325-7. doi: 10.1159/000237016.

Asthma and the beta agonist debate.哮喘与β受体激动剂之争

Thorax. 1995 Sep;50 Suppl 1(Suppl 1):S5-10. doi: 10.1136/thx.50.suppl_1.s5.

End of the New Zealand asthma mortality epidemic.

Lancet. 1995 Jan 7;345(8941):41-4. doi: 10.1016/s0140-6736(95)91159-6.

The proper role of beta 2-adrenergic agonists in the treatment of children with asthma.

Pediatrics. 1992 Oct;90(4):639-40.

引用本文的文献

Regular treatment with formoterol for chronic asthma: serious adverse events.福莫特罗用于慢性哮喘的常规治疗：严重不良事件

Cochrane Database Syst Rev. 2012 Apr 18;2012(4):CD006923. doi: 10.1002/14651858.CD006923.pub3.

Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events.福莫特罗常规治疗与沙美特罗常规治疗慢性哮喘的严重不良事件

Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD007695. doi: 10.1002/14651858.CD007695.pub3.

Current issues with beta2-adrenoceptor agonists: historical background.β2肾上腺素能受体激动剂的当前问题：历史背景

Clin Rev Allergy Immunol. 2006 Oct-Dec;31(2-3):107-18. doi: 10.1385/CRIAI:31:2:107.

Prevalence of asthma among schoolchildren in Patras, Greece: three surveys over 20 years.希腊帕特雷市学童哮喘患病率：20年间的三项调查

Thorax. 2001 Jul;56(7):569-71. doi: 10.1136/thorax.56.7.569.

Cardiovascular side effects of inhaled salbutamol in hypoxic asthmatic patients.缺氧性哮喘患者吸入沙丁胺醇的心血管副作用

Thorax. 2001 Jul;56(7):567-9. doi: 10.1136/thorax.56.7.567.

Age- and gender-specific asthma death rates in patients taking long-acting beta2-agonists: prescription event monitoring pharmacosurveillance studies.使用长效β2受体激动剂患者的年龄和性别特异性哮喘死亡率：处方事件监测药物警戒研究

Drug Saf. 2001;24(6):475-81. doi: 10.2165/00002018-200124060-00005.

The effects of salbutamol, beclomethasone, and dexamethasone on fibronectin expression by cultured airway smooth muscle cells.沙丁胺醇、倍氯米松和地塞米松对培养的气道平滑肌细胞纤连蛋白表达的影响。

Inflammation. 1999 Aug;23(4):321-31. doi: 10.1023/a:1020257532357.

beta-Adrenergic receptors contribute to hypoxaemia induced vasodilation in man.β-肾上腺素能受体在人类低氧血症诱导的血管舒张中起作用。

Br J Clin Pharmacol. 1995 Nov;40(5):453-8.

Asthma and the beta agonist debate.哮喘与β受体激动剂之争

Thorax. 1995 Sep;50 Suppl 1(Suppl 1):S5-10. doi: 10.1136/thx.50.suppl_1.s5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验